— Know what they know.
Not Investment Advice
Also trades as: GMAB.CO (CPH) · $vol 55M · GNMSF (OTC) · $vol 1M · GE9.F (FSX) · $vol 0M

GMAB Dark Pool Activity

Genmab A/S
1W: +14.3% 1M: +26.3% 3M: +56.6% YTD: +40.4% 1Y: +49.5% 3Y: +49.7% 5Y: -1.4%
$44.67
-0.01 (-0.03%)
 
Weekly Expected Move ±8.1%
$37 $40 $44 $47 $51
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Buy · Power 70 · $27.5B mcap · 587M float · 0.495% daily turnover · Short 61% of daily vol
Credit Risk of going bust: lower than 69% of companies Debt: 16.1% of company value Bonds: $301.5M held by 241 funds, 181 bp over Treasuries → details ▾
If the stock fell to about $0.65 (down 99%), Genmab A/S would be worth roughly what it owes.
Total debt $5.27B against a stock market value of $27.48B.
Distance to default 7.47 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $2.71B (short-term plus half of long-term), stock volatility 35.1%; Altman Z'' 3.61. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
No dark pool data available for GMAB.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms